169.86 USD
↗ 8.90 (5.53%)AT CLOSE (11:59 AM EDT)
Icon Plc
ICLRNASDAQ • USD
169.95
↗ 0.09 (0.05%)
POST MARKET (AS OF 05:45 PM EDT)
Post Market
AS OF 05:45 PM EDT
169.95
↗ 0.09 (0.05%)
Market: CLOSED
Icon Plc (ICLR) is currently trading at $169.86. The technical outlook is "Strong Buy" and the fundamental picture shows "Neutral". This is driven by a weak Piotroski F-Score of 0/9 and a bearish Death Cross on the long-term moving averages. On valuation, ICLR trades roughly in line with sector averages — neither particularly cheap nor expensive.
Technical & fundamental data as of Jun 26, 2026.
Open?$158.59
High?$170.51
Low?$158.59
Prev. Close?$160.96
Volume?1.4M
Avg. Volume?1.2M
VWAP?$168.13
Rel. Volume?1.23x
Bid / Ask
Bid?$143.14 × 100
Ask?$192.66 × 100
Spread?$49.52
Midpoint?$167.90
Valuation & Ratios
Market Cap?13.0B
Shares Out?76.4M
Float?80.3M
Float %?99.5%
P/E Ratio?38.52
P/B Ratio?6.73
EPS?$4.41
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Icon is a global contract research organization that provides outsourced clinical development services to pharmaceutical and biotechnology firms. Icon supports clients across late-stage clinical trials through the regulatory approval process and postmarket studies. Icon's services include clinical trial management, patient recruitment, data analytics, laboratory services, and regulatory consulting. With more than 40,000 employees operating in over 50 countries, the company partners with life sciences firms to run clinical trials and bring new drugs to market.
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+1/3)
Medium-Term (Wave)?▲ Bullish(+3/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?53
Momentum?50
Short Sent.?70
Piotroski F-Score?0/9Weak
Altman Z-Score?2.48Grey
Confidence?50%Low
Short InterestLow
Short % of Float?4.03%Low
Short Interest?3.2M
Days to Cover?2.9
Free Float80.3M
Avg Daily Volume1.1M
Settlement Date2026-06-15
Financial Health
Current Ratio?2.01Strong
Quick Ratio?2.01Strong
Cash Ratio?0.87Adequate
Debt/Equity?0.18Low
ValuationFAIRLY VALUEDvs 2 peers + S&P 500
Score56/100
P/E?38.5PRICEY▾
Peers50
S&P19
P/B?6.73FAIR▾
Peers33
S&P28
P/S?4.43FAIR▾
Peers33
S&P34
P/FCF?26.6FAIR▾
Peers67
S&P36
EV/EBITDA?26.5HIGH▾
Peers33
S&P14
EV/Sales?4.22FAIR▾
Peers33
S&P44
Returns & Efficiency
ROE?17.5%STRONG▾
Peers50
S&P61
ROA?9.7%STRONG▾
Peers100
S&P73
Cash Flow & Enterprise
FCF?$488.7M
Enterprise Value?$12.4B
Fundamentals ratios updated end of day